Table: Immuno Biological Lab - 9-MTH group results

Immuno-Biological Laboratories

12/02/2026 06:37

Feb 12 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            742 mln             680 mln           1.03     
                 (+9.1 pct)          (+24.0 pct)      (+5.7 pct)  
  Operating        223 mln             124 mln          240 mln   
                 (+79.1 pct)        (+1058.9 pct)     (+14.6 pct) 
  Recurring        236 mln             129 mln          240 mln   
                 (+82.7 pct)        (+401.0 pct)      (+14.4 pct) 
  Net              248 mln             133 mln          265 mln   
                 (+86.1 pct)        (+547.7 pct)      (+6.4 pct)  
  EPS             26.65 yen           14.32 yen        28.45 yen  
  Ann Div                                NIL           6.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL           6.00 yen   
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T